The Safety,Efficacy of Anti-EGFR Humanized Monoclonal Antibody Combined With Chemotherapy in Advanced Solid Tumors.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Advanced Solid Tumors
Related studies linked through entity extraction aliases.
Study to Evaluate CCS1477 in Advanced Tumours
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of ASP1948, Targeting an Immune Modulatory Receptor as a Single Agent and in Combination With a PD-l Inhibitor (Nivolumab or Pembrolizumab) in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of IBI310 for the Treatment of Patients With Advanced Solid Tumors.
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate the Safety, Tolerate, Pharmacokinetics and Preliminary Efficacy of CYH33
- Status
- COMPLETED
- Phase
- PHASE1
Study of the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Antitumor Activity of KN046 in Subjects With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
ORIOn-E: A Study Evaluating CPI-1205 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study Exploring the Safety and Tolerability of INCB081776 in Participants With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
FPA150 in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
A Study of Niraparib as Single Agent in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of an Anticancer Medication Combined With Immune Cells in Subjects With Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
A Phase I Study of MSB2311 in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Nivolumab Ipilimumab in Patients With hyperMutated Cancers Detected in Blood (NIMBLe)
- Status
- TERMINATED
- Phase
- PHASE2
A Phase 1 Dose-escalation Study of FF-10832 for Treatment of Solid Tumors Including Biliary Tract Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
An Open-label Phase I/II Clinical Trial of PT-112 Injection for Advanced Solid Tumors and Advanced Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss
- Status
- TERMINATED
- Phase
- PHASE1
First-in-human Study of Oral TP-0184 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Clinical Study of HWH340 Tablet in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
MGD009/MGA012 Combination in Relapsed/Refractory Cancer
- Status
- COMPLETED
- Phase
- PHASE1